Aetion Revenue and Competitors

Location

$203.6M

Total Funding

Estimated Revenue & Valuation

  • Aetion's estimated annual revenue is currently $58.7M per year.(i)
  • Aetion received $27.0M in venture funding in February 2019.
  • Aetion's estimated revenue per employee is $177,800
  • Aetion's total funding is $203.6M.

Employee Data

  • Aetion has 330 Employees.(i)
  • Aetion grew their employee count by -16% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27.2M181-36%$162.2MN/A
#2
$3.8M3470%N/AN/A
#3
$3.6M32-18%N/AN/A
#4
$58.9M331-17%$26.9MN/A
#5
$4.7M4227%N/AN/A
#6
$197M1502-8%$112.6MN/A
#7
$22.6M150-8%$45MN/A
#8
$21.6M0N/A$13.2MN/A
#9
$4070M4236-21%$1.9BN/A
#10
$5.4M4823%N/AN/A
Add Company

Aetion offers the world's most advanced and fastest growing real-world evidence platform, accelerating the development and impact of treatments. With its patented rapid-cycle analytics technology, the Aetion platform uses the everyday clinical and financial interactions of health care to unlock essential evidence about treatment effectiveness and value. Founded by Harvard Medical School faculty members and a pioneer in big data, Aetion helps biopharma and payers and, most importantly, patients thrive in the era of value-based care. Visit aetion.com and learn how Aetion, together with its biopharma and payer customers, is advancing the global adoption of real-world evidence for critical health care decisions.

keywords:Healthcare,Pharmaceuticals, saas

$203.6M

Total Funding

330

Number of Employees

$58.7M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Aetion News

2022-03-22 - Aetion and Cognito Team Up for Predictive Modeling in ...

Aetion, real-world evidence (RWE) tech and analytics provider, and Cognito Therapeutics, a pioneer in neuromodulation therapeutics for...

2022-03-22 - Effectiveness of Ad26.COV2.S Vaccine Stable for Six Months

D., M.P.H., from Aetion Inc. in New York City, and colleagues examined the association between receipt of Ad26.COV2.S vaccine and COVID-19-...

2021-09-14 - Aetion Welcomes Marla Kessler as First Chief Customer Officer To Accelerate Its Next Phase of Growth

NEW YORK, Sept. 14, 2021 /PRNewswire/ -- Aetion, a leading health technology company, announces that Marla Kessler will become its first Chief Customer Officer. Kessler will lead Aetion's efforts to create superior customer experiences, oversee marketing and communications teams, and support t ...

2021-05-12 - Aetion doubles lifetime funding with $110M series C for real-world data platform

Thanks to a 2020 spent proving the usefulness of its real-world evidence platform in rapidly responding to a global health crisis, Aetion has more than doubled its total venture funding to date with the close of a $110 million series C. RELATED: FDA, Aetion dive into the real-world data surroun ...

2021-05-11 - Aetion : Closes $110M Series C Funding Round Led by Warburg Pincus

BOSTON and NEW YORK, May 11, 2021 /PRNewswire/ -- Health care technology company Aetion announced today a $110 million Series C fundraise, led by Warburg Pincus, a leading global growth equity firm, with additional investments from B Capital and Foresite Capital. Aetion's existing backers New En ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$103.1M33018%N/A
#2
$54.5M3300%N/A
#3
$49.5M3308%N/A
#4
$61.9M330N/AN/A
#5
$86.9M33177%N/A

Aetion Funding

DateAmountRoundLead InvestorsReference
2017-03-21$11.2MAFlare Capital PartnersArticle
2018-04-12$36.0MBNew Enterprise Associates (NEA)Article
2019-02-06$27.0MUndisclosedMULTIPLEArticle